SEC Tracker
Get the app

Innospec IOSP

Innospec FY 2025: revenue $1.8B, down 4%; diluted EPS $4.67

Form
10-K
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Innospec reported for the year ended Dec 31, 2025, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$1.8B−4% from $1.8B in FY 202410-K income statement, on EDGAR
  2. Diluted EPS$4.67+229% from $1.42 in FY 202410-K income statement, on EDGAR
  3. Cash and cash equivalents$292.5M+1% from $289.2M in FY 202410-K balance sheet, on EDGAR
  4. Cash from operations$138.3M−25% from $184.5M in FY 202410-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Innospec files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2800 and related industry codes: the same peer list as the financial tables.

  1. Ingevity NGVT public float $1.6B, Jun 30, 2025
  2. Chemours CC public float $1.7B, Jun 30, 2025
  3. Huntsman HUN public float $1.7B, Jun 30, 2025
  4. Ecovyst ECVT public float $933M, Jun 30, 2025
  5. Perimeter Solutions PRM public float $1.9B, Jun 30, 2025